Ben McPoland considers a pair of investments that are performing awfully in his ISA portfolio so far this year. What's gone ...

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading organizations and providers across ...

Amy Schumer had some positive praise for Mounjaro after a not-so-great experience with Wegovy years prior. "Three years ago, ...

Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.

Cube will underpin many of the AI tools we will develop in the years to come, including highly complex scene-generation tools ...

Rosie O'Donnell provides an update on her weight loss journey during a TikTok video posted on Thursday, March 20. The Emmy Award winner shares that she has continued to lose weight since starting ...

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

GLP-1 medications like Wegovy and Ozempic have become popular options for managing conditions like diabetes and obesity, but hair loss is a lesser-known side effect.

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...